Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC] - N0000194088

Pharmacologic Class Information

Pharmacologic Code N0000194088
Pharmacologic Name Human Immunodeficiency Virus 1 Capsid Inhibitor
Pharmacologic Uses
  • human immunodeficiency virus type 1 (HIV-1) capsid inhibitor
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Human Immunodeficiency Virus 1 Capsid Inhibitor

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
61958-3001Sunlenca Non-Proprietary Name: Lenacapavir SodiumTablet, Film CoatedOralGilead Sciences, Inc.ACTIVE
61958-3401Yeztugo Non-Proprietary Name: Lenacapavir SodiumTablet, Film CoatedOralGilead Sciences, Inc.ACTIVE